Avalo Therapeutics (AVTX) FCF Margin (QoQ) (2016 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -320,610.00 |
| Dec 31, 2023 | 241,220.00 |
| Sep 30, 2023 | -118,184.00 |
| Jun 30, 2023 | 43,470.00 |
| Mar 31, 2023 | -172,034.00 |
| Dec 31, 2022 | -46,717.00 |
| Sep 30, 2022 | 125,063.00 |
| Jun 30, 2022 | 15,715.00 |
| Mar 31, 2022 | 644,305.00 |
| Dec 31, 2021 | -660,012.00 |
| Sep 30, 2021 | -64,077.00 |
| Jun 30, 2021 | 330,485.00 |
| Mar 31, 2021 | -291,649.00 |
| Dec 31, 2020 | 11,382.00 |
| Sep 30, 2020 | -43,469.00 |
| Jun 30, 2020 | -43,100.00 |
| Mar 31, 2020 | 8,093.00 |
| Dec 31, 2019 | 5,686.00 |
| Sep 30, 2019 | 14,294.00 |
| Jun 30, 2019 | -36,152.00 |
| Mar 31, 2019 | -16,680.00 |
| Dec 31, 2018 | 5,337.00 |
| Sep 30, 2018 | -706.00 |
| Jun 30, 2018 | -43.00 |
| Mar 31, 2018 | 12,751.00 |
| Dec 31, 2017 | -21,055.00 |
| Sep 30, 2017 | 119,109.00 |
| Jun 30, 2017 | -53,217.00 |
| Mar 31, 2017 | 146,259.00 |
| Dec 31, 2016 | -97,503.00 |
| Sep 30, 2016 | -49,673.00 |